10x Genomics, Inc. TXG Return on equity

Return on equity at other companies

TEC

Bio-TechneTECH

6.5%-3.9pp

BrukerBRKR

-1%-21.2pp

IlluminaILMN

32.4%-35.7pp

Agilent TechnologiesA

21.3%+2.4pp

Quanterix CorporationQTRX

-34.8%-122pp

Bio-Rad LaboratoriesBIO

2.5%+1.3pp

FAQ

What is 10x Genomics, Inc.'s return on equity?

10x Genomics, Inc. (TXG) reported return on equity of -9.4% in Q2 2026.

How has 10x Genomics, Inc.'s return on equity changed year-over-year?

10x Genomics, Inc.'s return on equity increased by 16.8% year-over-year, from -11.3% to -9.4%.

What is the long-term trend for 10x Genomics, Inc.'s return on equity?

Over 5 years (2020 to 2025), 10x Genomics, Inc.'s return on equity has grown at a -42.7% compound annual growth rate (CAGR), from -93.6% to -5.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.